JPY1,966.50
2.38% today
Tokyo, Jun 13, 08:15 am CET
ISIN
JP3435750009
Symbol
2413
Index

M3 Stock price

JPY1,972.50
+37.50 1.94% 1M
+547.50 38.42% 6M
+575.50 41.20% YTD
+459.50 30.37% 1Y
-2,357.50 54.45% 5Y
+766.50 63.56% 10Y
+1,813.75 1,142.52% 20Y
Tokyo, Closing price Fri, Jun 13 2025
-42.00 2.08%
ISIN
JP3435750009
Symbol
2413
Index

Key metrics

Market capitalization JPY1.41t
Enterprise Value JPY1.27t
P/E (TTM) P/E ratio 33.79
EV/FCF (TTM) EV/FCF 29.70
EV/Sales (TTM) EV/Sales 4.46
P/S ratio (TTM) P/S ratio 4.96
P/B ratio (TTM) P/B ratio 3.61
Dividend yield 1.04%
Last dividend (FY24) JPY21.00
Revenue growth (TTM) Revenue growth 19.26%
Revenue (TTM) Revenue JPY284.90b
EBIT (operating result TTM) EBIT JPY60.30b
Free Cash Flow (TTM) Free Cash Flow JPY42.75b
Cash position JPY166.75b
EPS (TTM) EPS JPY59.62
P/E forward 29.27
P/S forward 3.95
EV/Sales forward 3.55
Show more

Is M3 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

M3 Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a M3 forecast:

5x Buy
36%
9x Hold
64%

Analyst Opinions

14 Analysts have issued a M3 forecast:

Buy
36%
Hold
64%

Financial data from M3

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
284,900 284,900
19% 19%
100%
- Direct Costs 130,536 130,536
33% 33%
46%
154,364 154,364
10% 10%
54%
- Selling and Administrative Expenses 92,946 92,946
24% 24%
33%
- Research and Development Expense - -
-
-
72,504 72,504
1% 1%
25%
- Depreciation and Amortization 12,205 12,205
37% 37%
4%
EBIT (Operating Income) EBIT 60,299 60,299
4% 4%
21%
Net Profit 40,484 40,484
11% 11%
14%

In millions JPY.

Don't miss a Thing! We will send you all news about M3 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Itaru Tanimura
Employees 12,100
Founded 2000
Website corporate.m3.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today